DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,498,082 | -62.7% | 634,720 | -0.3% | 0.00% | – |
| Q2 2023 | $4,012,123 | +9.8% | 636,845 | +0.6% | 0.00% | – |
| Q1 2023 | $3,652,456 | +58943.9% | 633,008 | +5.0% | 0.00% | -100.0% |
| Q4 2022 | $6,186 | -99.9% | 603,013 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $9,642,000 | +58.3% | 576,709 | +32.5% | 0.00% | 0.0% |
| Q2 2022 | $6,091,000 | +2.9% | 435,125 | +18.6% | 0.00% | 0.0% |
| Q1 2022 | $5,922,000 | -21.3% | 366,745 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $7,524,000 | +98.5% | 351,441 | +36.2% | 0.00% | 0.0% |
| Q3 2021 | $3,790,000 | -24.6% | 258,032 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $5,027,000 | +346.1% | 252,760 | +570.5% | 0.00% | – |
| Q1 2021 | $1,127,000 | – | 37,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |